Publications

2018

  1. Salaroglio I. C., Gazzano E., Abdullrahman A. et_al. (2018) Journal Of Experimental & Clinical Cancer Research. 37, 286.  Abstract
  2. Kopecka J., Salaroglio I. C., Righi L. et_al. (2018) Lung Cancer. 120, p. 34-45  Abstract
  3. Rubinstein M. & Dvash E. (2018) Current Opinion in Nephrology and Hypertension. 27, 1, p. 42-48  Abstract
  4. Rubinstein M. (2018) The journal of Biological chemistry. 293, 1, p. 112-112  Abstract

2017

  1. Salaroglio I. C., Panada E., Moiso E., Buondonno I., Provero P., Rubinstein M., Kopecka J. & Riganti C. (2017) Molecular Cancer. 16,  Abstract
  2. Wassermann Dozorets D. R. & Rubinstein M. (2017) Cell Death & Disease. 8, 2733.  Abstract

2016

  1. Dvash E. & Rubinstein M. (2016) Cell cycle (Georgetown, Tex.). 15, 7, p. 869-70 26890977.  Abstract

2015

  1. Dvash E., Har-Tal M., Barak S., Meir O. & Rubinstein M. (2015) Nature Communications. 6, p. 10112-10112  Abstract
  2. Riganti C., Kopecka J., Panada E., Barak S. & Rubinstein M. (2015) JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 107, 5, djv046.  Abstract

2014

  1. FABP4 Attenuates PPAR gamma and Adipogenesis and Is Inversely Correlated With PPARg in Adipose Tissues
    Garin-Shkolnik T., Rudich A., Hotamisligil G. S. & Rubinstein M. (2014) Diabetes. 63, 3, p. 900-911  Abstract

2013

  1. Finkelshtein D., Werman A., Novick D., Barak S. & Rubinstein M. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 18, p. 7306-7311  Abstract

2012

  1. Shechter Y., Sasson K., Lev Goldman G. V., Rubinraut S., Rubinstein M. & Fridkin M. (2012) Bioconjugate Chemistry. 23, 8, p. 1577-1586  Abstract

2011

  1. Novick D. & Rubinstein M. (2011) Cytokine Protocols. p. 195-214 (Methods in Molecular Biology).  Abstract
  2. Zhang W., Lin M., Winesett A. et_al. (2011) Polymers for Advanced Technologies. 22, 1, p. 65-71  Abstract

2010

  1. Meir O., Dvash E., Werman A. & Rubinstein M. (2010) PLoS One. 5, 3, e9516.  Abstract
  2. Novick D., Elbirt D., Miller G., Dinarello C. A., Rubinstein M. & Sthoeger Z. M. (2010) Journal of Autoimmunity. 34, 2, p. 121-126  Abstract

2009

  1. Novick D., Elbirt D., Dinarello C. A., Rubinstein M. & Sthoeger Z. M. (2009) Journal of Clinical Immunology. 29, 1, p. 38-45  Abstract

2008

  1. Werman A., Alkahe B., Dinarello C. A. & Rubinstein M. (2008) Cytokine. 43, 3, p. 307-307  Abstract
  2. Werman A., Korba B. E., Alkahe B., Finkelshtein D., Bujanover S., Novick D., Vinocour E. & Rubinstein M. (2008) Cytokine. 43, 3, p. 249-249  Abstract

2007

  1. Thompson S. R., Novick D., Stock C. J. et_al. (2007) ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 27, 12, p. 2743-2749  Abstract
  2. Novick D. & Rubinstein M. (2007) Cytokine & Growth Factor Reviews. 18, 6-May, p. 525-533  Abstract
  3. Rubinstein M. (2007) Cytokine & Growth Factor Reviews. 18, 6-May, p. 519-524  Abstract
  4. Spiegel A., Shivtiel S., Kalinkovich A. et_al. (2007) Nature Immunology. 8, 10, p. 1123-1131  Abstract
  5. Naftali T., Novick D., Gabay G., Rubinstein M. & Novis B. (2007) Israel Medical Association Journal. 9, 7, p. 504-508  Abstract
  6. Hurgin V., Novick D., Werman A., Dinarello C. A. & Rubinstein M. (2007) Cytokine. 39, 1, p. 17-17  Abstract
  7. Thompson S. R., Novick D., Stock C., Rubinstein M., Woo P., Humphries S. E. & Sanders J. (2007) Atherosclerosis Supplements. 8, 1, p. 52-52  Abstract
  8. Birk R. Z. & Rubinstein M. (2007) Biochemical and Biophysical Research Communications. 355, 3, p. 626-631  Abstract
  9. Hurgin V., Novick D., Werman A., Dinarello C. A. & Rubinstein M. (2007) Proceedings of the National Academy of Sciences of the United States of America. 104, 12, p. 5044-5049  Abstract

2006

  1. Birk R. & Rubinstein M. (2006) Biochemical and Biophysical Research Communications. 345, 2, p. 669-674  Abstract
  2. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C. & Kim S. (2006) Proceedings of the National Academy of Sciences of the United States of America. 103, 9, p. 3316-3321  Abstract

2005

  1. Neumayr G., Ludwiczek O., Hoertnagl H., Pfister R., Mitterbauer G., Moschen A., Novick D., Rubinstein M. & Tilg H. (2005) International Journal of Sports Medicine. 26, 10, p. 836-840  Abstract
  2. Mazodier K., Marin V., Novick D. et_al. (2005) Blood. 106, 10, p. 3483-3489  Abstract
  3. Shechter Y., Tsubery H., Mironchik M., Rubinstein M. & Fridkin M. (2005) FEBS Letters. 579, 11, p. 2439-2444  Abstract
  4. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease
    Ludwiczek O., Kaser A., Novick D., Dinarello C., Rubinstein M. & Tilg H. (2005) European Cytokine Network. 16, 1, p. 27-33  Abstract

2004

  1. Gutman G., Har-Toov J., Many A., Lessing J., Novick D., Rubinstein M. & Jaffa A. (2004) American Journal of Obstetrics and Gynecology. 191, 6, p. S152-S152  Abstract
  2. Barkan D., Hurgin V., Dekel N., Amsterdam A. & Rubinstein M. (2004) FASEB Journal. 18, 13, p. 133-+  Abstract
  3. Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: Relationship between defects and ethnic groups
    Shevah O., Rubinstein M. & Laron Z. (2004) Israel Medical Association Journal. 6, 10, p. 630-633  Abstract
  4. Kawashima M., Novick D., Rubinstein M. & Miossec P. (2004) Arthritis and Rheumatology. 50, 6, p. 1800-1805  Abstract
  5. Classical phenotype of Laron syndrome in a girl with a heterozygous mutation and heterozygous polymorphism of the growth hormone receptor gene
    Shevah O., Galli-Tsinopoulou A., Rubinstein M., Nousia-Arvanitakis S. & Laron Z. (2004) Journal Of Pediatric Endocrinology & Metabolism. 17, 3, p. 371-374  Abstract
  6. Tomiyama K., McNamara F., Clifford J. et_al. (2004) Synapse. 51, 1, p. 71-81  Abstract

2003

  1. Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex
    Azam T., Novick D., Bufler P., Yoon D., Rubinstein M., Dinarello C. & Kim S. (2003) Journal of Immunology. 171, 12, p. 6574-6580  Abstract
  2. Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure
    Lonnemann G., Novick D., Rubinstein M. & Dinarello C. (2003) Clinical Nephrology. 60, 5, p. 327-334  Abstract
  3. Feezor R., Oberholzer C., Baker H. et_al. (2003) Infection and Immunity. 71, 10, p. 5803-5813  Abstract
  4. Identification of two novel mutations in the human growth hormone receptor gene
    Shevah O., Borrelli P., Rubinstein M. & Laron Z. (2003) Journal of Endocrinological Investigation. 26, 7, p. 604-608  Abstract
  5. Gangemi S., Basile G., Merendino R. et_al. (2003) Experimental Gerontology. 38, 6, p. 669-672  Abstract
  6. Lonnemann G., Novick D., Rubinstein M., Passlick-Deetjen J., Lang D. & Dinarello C. (2003) Blood Purification. 21, 3, p. 225-231  Abstract
  7. Dinarello C., Novick D., Rubinstein M. & Lonnemann G. (2003) Blood Purification. 21, 3, p. 258-270  Abstract
  8. Nolsoe R., Pociot F., Novick D., Rubinstein M., Kim S., Dinarello C. & Mandrup-Poulsen T. (2003) Immunology Of Diabetes Ii: Pathogenesis From Mouse To Man. 1005, p. 332-339  Abstract
  9. Stuyt R., Kim S., Reznikov L. et_al. (2003) Cytokine. 21, 2, p. 65-73  Abstract

2002

  1. Hurgin V., Novick D. & Rubinstein M. (2002) Proceedings of the National Academy of Sciences of the United States of America. 99, 26, p. 16957-16962  Abstract
  2. Ludwiczek O., Kaser A., Novick D., Dinarello C., Rubinstein M., Vogel W. & Tilg H. (2002) Journal of Clinical Immunology. 22, 6, p. 331-337  Abstract
  3. Sandowski Y., Raver N., Gussakovsky E., Shochat S., Dym O., Livnah O., Rubinstein M., Krishna R. & Gertler A. (2002) Journal of Biological Chemistry. 277, 48, p. 46304-46309  Abstract
  4. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury
    Yatsiv I., Morganti-Kossmann M., Perez D. et_al. (2002) Journal of Cerebral Blood Flow and Metabolism. 22, 8, p. 971-978  Abstract
  5. Kaser A., Novick D., Rubinstein M. et_al. (2002) Clinical and Experimental Immunology. 129, 2, p. 332-338  Abstract
  6. IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components
    Ariel A., Novick D., Rubinstein M., Dinarello C., Lider O. & Hershkoviz R. (2002) Journal of Leukocyte Biology. 72, 1, p. 192-198  Abstract
  7. Intronic mutation in the growth hormone receptor gene in a Peruvian girl with Laron syndrome
    Shevah O., Nunez O., Rubinstein M. & Laron Z. (2002) Journal Of Pediatric Endocrinology & Metabolism. 15, 7, p. 1039-1040  Abstract
  8. Kim S., Azam T., Novick D., Yoon D., Reznikov L., Bufler P., Rubinstein M. & Dinarello C. (2002) Journal of Biological Chemistry. 277, 13, p. 10998-11003  Abstract

2001

  1. Zecchina G., Novick D., Rubinstein M., Barak V., Dinarello C. & Nagler A. (2001) Journal Of Hematotherapy & Stem Cell Research. 10, 6, p. 769-776  Abstract
  2. Almog B., Gold R., Tajima K. et_al. (2001) Molecular and Cellular Endocrinology. 183, 2-Jan, p. 179-191  Abstract
  3. Stuyt R., Netea M., Kim S., Novick D., Rubinstein M., Kullberg B., Van der Meer d. M. J. & Dinarello C. (2001) Infection and Immunity. 69, 8, p. 5025-5030  Abstract
  4. Novick D., Schwartsburd B., Pinkus R. et_al. (2001) Cytokine. 14, 6, p. 334-342  Abstract
  5. Arazi T., Slutsky S., Shiboleth Y., Wang Y., Rubinstein M., Barak S., Yang J. & Gal-On A. (2001) Journal of Biotechnology. 87, 1, p. 67-82  Abstract
  6. Kim S., Azam T., Yoon D., Reznikov L., Novick D., Rubinstein M. & Dinarello C. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 6, p. 3304-3309  Abstract
  7. Cohen B., Barkan D., Levy Y., Goldberg I., Fridman E., Kopolovic J. & Rubinstein M. (2001) Journal of Biological Chemistry. 276, 11, p. 7697-7700  Abstract

2000

  1. Novick D., Nabioullin R., Ragsdale W. et_al. (2000) Journal of Interferon and Cytokine Research. 20, 11, p. 971-982  Abstract
  2. Liu B., Novick D., Kim S. & Rubinstein M. (2000) Cytokine. 12, 10, p. 1519-1525  Abstract
  3. Harvesting the human genome: the Israeli perspective
    Ben-Asher E., Chalifa-Caspi V., Horn-Saban S. et_al. (2000) Israel Medical Association Journal. 2, 9, p. 657-664  Abstract
  4. Kim S., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M. & Dinarello C. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 3, p. 1190-1195  Abstract
  5. Reznikov L., Kim S., Westcott J., Frishman J., Fantuzzi G., Novick D., Rubinstein M. & Dinarello C. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 5, p. 2174-2179  Abstract
  6. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L. et_al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 2, p. 734-739  Abstract

1999

  1. Barkan D., Jia H., Dantes A., Vardimon L., Amsterdam A. & Rubinstein M. (1999) Endocrinology. 140, 4, p. 1731-1738  Abstract
  2. Novick D., Kim S., Fantuzzi G., Reznikov L., Dinarello C. & Rubinstein M. (1999) Immunity. 10, 1, p. 127-136  Abstract

1998

  1. Zelzer E., Levy Y., Kahana C., Shilo B., Rubinstein M. & Cohen B. (1998) EMBO Journal. 17, 17, p. 5085-5094  Abstract
  2. Recent advances in cytokines, cytokine receptors and signal transduction
    Rubinstein M., Dinarello C., Oppenheim J. & Hertzog P. (1998) Cytokine & Growth Factor Reviews. 9, 2, p. 175-181  Abstract
  3. Overview of interleukin-18: more than an interferon-gamma inducing factor
    Dinarello C., Novick D., Puren A. et_al. (1998) Journal of Leukocyte Biology. 63, 6, p. 658-664  Abstract

1997

  1. Kim S., Cohen B., Novick D. & Rubinstein M. (1997) Gene. 196, 2-Jan, p. 279-286  Abstract
  2. Mechanism(s) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis
    Ambrus J., Chadha S., Novick D., Rubinstein M., Gopalakrishnan B., Bernstein Z., Priore R. & Chadha K. (1997) Research Communications in Molecular Pathology and Pharmacology. 96, 3, p. 255-265  Abstract

1996

  1. Cohen B., Novick D. & Rubinstein M. (1996) Science. 274, 5290, p. 1185-1188  Abstract
  2. Gamus D., Romano A., Rubinstein M. & Savion N. (1996) Experimental Eye Research. 63, 1, p. 1-7  Abstract

1995

  1. CLONING AND EXPRESSION OF A LONG FORM OF THE BETA-SUBUNIT OF THE INTERFERON ALPHA-BETA RECEPTOR THAT IS REQUIRED FOR SIGNALING
    DOMANSKI P., WITTE M., KELLUM M., Rubinstein M., HACKETT R., PITHA P. & COLAMONICI O. (1995) Journal of Biological Chemistry. 270, 37, p. 21606-21611  Abstract
  2. LIGAND-INDUCED ASSOCIATION OF THE TYPE-I INTERFERON RECEPTOR COMPONENTS
    Cohen B., Novick D., Barak S. & Rubinstein M. (1995) Molecular and Cellular Biology. 15, 8, p. 4208-4214  Abstract
  3. SOLUBLE AND MEMBRANE-ANCHORED FORMS OF THE HUMAN IFN-ALPHA/BETA RECEPTOR
    Novick D., Cohen B., Tal N. & Rubinstein M. (1995) Journal of Leukocyte Biology. 57, 5, p. 712-718  Abstract

1994

  1. ISOLATION AND CHARACTERIZATION OF A SOLUBLE FORM OF THE LDL RECEPTOR, AN INTERFERON-INDUCED ANTIVIRAL PROTEIN
    FISCHER D., Novick D., Cohen B. & Rubinstein M. (1994) Proceedings Of The Society For Experimental Biology And Medicine. 206, 3, p. 228-232  Abstract
  2. THE SECRETED TUMOR-ASSOCIATED ANTIGEN 90K IS A POTENT IMMUNE STIMULATOR
    ULLRICH A., SURES I., DEGIDIO M. et_al. (1994) Journal of Biological Chemistry. 269, 28, p. 18401-18407  Abstract
  3. Novick D., Cohen B. & Rubinstein M. (1994) Cell. 77, 3, p. 391-400  Abstract

1993

  1. FISCHER D., Tal N., Novick D., Barak S. & Rubinstein M. (1993) Science. 262, 5131, p. 250-253  Abstract
  2. Rubinstein M. (1993) Bio-Technology. 11, 4, p. 420-420  Abstract

1992

  1. Novick D., Cohen B. & Rubinstein M. (1992) FEBS Letters. 314, 3, p. 445-448  Abstract
  2. EDELBAUM O., STEIN D., HOLLAND N., GAFNI Y., Livneh O., Novick D., Rubinstein M. & Sela I. (1992) Journal of Interferon Research. 12, 6, p. 449-453  Abstract
  3. REITER Z., LOYTER A., NUSSBAUM O. & Rubinstein M. (1992) Cellular Immunology. 142, 2, p. 370-384  Abstract
  4. INTERLEUKIN-6 PROTECTS DUCTAL BREAST-CARCINOMA CELLS FROM MHC-UNRESTRICTED CELL-MEDIATED CYTOTOXICITY
    REITER Z., CHEN L., Revel M. & Rubinstein M. (1992) Journal of Interferon and Cytokine Research. 11, 3, p. 175-181  Abstract

1991

  1. RESISTANCE TO NK-CELL-MEDIATED CYTOTOXICITY (IN K-562 CELLS) DOES NOT CORRELATE WITH CLASS-I MHC ANTIGEN LEVELS
    REITER Z., REITER Y., FISHELSON Z., SHINITZKY M., KESSLER A., LOYTER A., NUSSBAUM O. & Rubinstein M. (1991) Immunobiology. 183, 2-Jan, p. 23-39  Abstract
  2. EDELBAUM O., SHER N., Rubinstein M., Novick D., Tal N., MOYER M., WARD E., RYALS J. & Sela I. (1991) Plant Molecular Biology. 17, 1, p. 171-173  Abstract
  3. YONISHROUACH E., Kimchi A. & Rubinstein M. (1991) Transplantation. 51, 6, p. 1276-1282  Abstract
  4. YONISHROUACH E., FISCHER D. & Rubinstein M. (1991) Cellular Immunology. 134, 2, p. 402-413  Abstract
  5. Novick D., ENGELMANN H., Revel M., Leitner O. & Rubinstein M. (1991) Hybridoma. 10, 1, p. 137-146  Abstract
  6. MERIMSKY O., Rubinstein M., FISCHER D., Danon A. & CHAITCHIK S. (1991) Cancer Chemotherapy and Pharmacology. 27, 5, p. 406-408  Abstract
  7. PRODUCTION, DOWNSTREAM PROCESSING AND CHARACTERIZATION OF PROTEINS FROM RECOMBINANT ANIMAL-CELLS - THE CASE OF HUMAN INTERFERON-BETA
    Rubinstein M., Revel M., Novick D. et_al. (1991) Biologicals From Recombinant Microorganisms And Animal Cells: Production And Recovery. p. 479-486  Abstract

1990

  1. YONISHROUACH E., SHINITZKY M. & Rubinstein M. (1990) Journal of Immunological Methods. 135, 2-Jan, p. 147-153  Abstract
  2. Harel A. (., FAINARU M., Rubinstein M., Tal N. & Schwartz M. (1990) Journal of Neurochemistry. 55, 4, p. 1237-1243  Abstract
  3. LAZARD D., Tal N., Rubinstein M., Khen M., Lancet D. & ZUPKO K. (1990) Biochemistry. 29, 32, p. 7433-7440  Abstract
  4. Novick D., ENGELMANN H., Wallach D., Leitner O., Revel M. & Rubinstein M. (1990) Journal of Chromatography. 510, p. 331-337  Abstract
  5. SOLUBLE FORMS OF THE TNF RECEPTORS, PURIFIED FROM HUMAN URINE, INHIBIT TNF EFFECTS - ANTIBODIES AGAINST THE SOLUBLE RECEPTORS INDUCE TNF-LIKE EFFECTS
    ENGELMANN H., ADERKA D., HOLTMANN H. et_al. (1990) Molecular And Cellular Biology Of Cytokines. 10, p. 299-308  Abstract
  6. EDELBAUM O., ILAN N., GRAFI G., SHER N., STRAM Y., Novick D., Tal N., Sela I. & Rubinstein M. (1990) Proceedings of the National Academy of Sciences of the United States of America. 87, 2, p. 588-592  Abstract
  7. MECHANISMS INVOLVED IN REGULATION OF THE RESPONSE TO TUMOR-NECROSIS-FACTOR - POSSIBLE ROLES FOR PROSTAGLANDIN PRODUCTION IN SENSITIZATION TO TNF EFFECTS AND FOR A SPECIFIC TNF-BINDING PROTEIN IN PROTECTION FROM THEM
    Wallach D., ADERKA D., Rubinstein M., ENGELMANN H., AVNI Y., SAROV I. & HOLTMANN H. (1990) Tumor Necrosis Factor : Structure, Mechanism Of Action, Role In Disease And Therapy. p. 146-155  Abstract
  8. SOLUBLE CYTOKINE-RECEPTORS ARE PRESENT IN NORMAL HUMAN URINE
    Novick D., ENGELMANN H., Wallach D. & Rubinstein M. (1990) Physiological And Pathological Effects Of Cytokines. 10, p. 413-421  Abstract

1989

  1. Novick D., ENGELMANN H., Wallach D. & Rubinstein M. (1989) Journal of Experimental Medicine. 170, 4, p. 1409-1414  Abstract
  2. A TUMOR NECROSIS FACTOR-BINDING PROTEIN PURIFIED TO HOMOGENEITY FROM HUMAN-URINE PROTECTS CELLS FROM TUMOR NECROSIS FACTOR TOXICITY
    ENGELMANN H., ADERKA D., Rubinstein M., ROTMAN D. & Wallach D. (1989) Journal of Biological Chemistry. 264, 20, p. 11974-11980  Abstract
  3. Novick D., FISCHER D., REITER Z., Eshhar Z. & Rubinstein M. (1989) Journal of Interferon Research. 9, 3, p. 315-328  Abstract
  4. BIOLOGICAL-ACTIVITIES OF RECOMBINANT HUMAN IFN-BETA-2 IL-6 (ESCHERICHIA-COLI)
    Revel M., ZILBERSTEIN A., CHEN L., GOTHELF Y., BARASH I., Novick D., Rubinstein M. & MICHALEVICZ R. (1989) Annals of the New York Academy of Sciences. 557, p. 144-156  Abstract
  5. BIOLOGICAL-ACTIVITIES OF RECOMBINANT HUMAN IFN-BETA-2/IL-6 (ESCHERICHIA-COLI)
    Revel M., ZILBERSTEIN A., CHEN L., GOTHELF Y., BARASH I., Novick D., Rubinstein M. & MICHALEVICZ R. (1989) Regulation Of The Acute Phase And Immune Responses : Interleukin-6. 557, p. 144-156  Abstract
  6. MECHANISMS WHICH TAKE PART IN REGULATION OF THE RESPONSE TO TUMOR NECROSIS FACTOR
    Wallach D., HOLTMANN H., ADERKA D., Rubinstein M., AVNI Y., SAROV I. & ENGELMAN H. (1989) Lymphokine Research. 8, 3, p. 359-363  Abstract

1988

  1. THE MYELOID BLOOD-CELL DIFFERENTIATION INDUCING PROTEIN MGI-2A IS INTERLEUKIN-6
    SHABO Y., Lotem J., Rubinstein M., Revel M., CLARK S., WOLF S., KAMEN R. & Sachs L. (1988) Blood. 72, 6, p. 2070-2073  Abstract
  2. CHEN L., Novick D., Rubinstein M. & Revel M. (1988) FEBS Letters. 239, 2, p. 299-304  Abstract
  3. 2 MOLECULAR-FORMS OF THE HUMAN INTERFERON-GAMMA RECEPTOR - LIGAND-BINDING, INTERNALIZATION, AND DOWN-REGULATION
    FISCHER D., Novick D., ORCHANSKY P. & Rubinstein M. (1988) Journal of Biological Chemistry. 263, 6, p. 2632-2637  Abstract

1987

  1. Revel M., ZILBERSTEIN A., RUGGIERI R., Rubinstein M. & CHEN L. (1987) Journal of Interferon Research. 7, 5, p. 529-536  Abstract
  2. Rubinstein M. (1987) Journal of Interferon Research. 7, 5, p. 545-551  Abstract
  3. THE HUMAN INTERFERON-GAMMA RECEPTOR - PURIFICATION, CHARACTERIZATION, AND PREPARATION OF ANTIBODIES
    Novick D., ORCHANSKY P., Revel M. & Rubinstein M. (1987) Journal of Biological Chemistry. 262, 18, p. 8483-8487  Abstract
  4. Rubinstein M., Novick D. & FISCHER D. (1987) Immunological Reviews. 97, p. 29-50  Abstract

1986

  1. Goren T., FISCHER D. & Rubinstein M. (1986) Journal of Interferon Research. 6, 4, p. 323-329  Abstract
  2. HUMAN-MONOCYTES TUMORICIDAL ACTIVITY - THE ROLE OF INTERFERON-GAMMA AND BACTERIAL LIPOPOLYSACCHARIDE IN ITS STIMULATION, PRESERVATION AND DECAY
    FISCHER D. & Rubinstein M. (1986) Immunobiology. 172, 2-Jan, p. 110-119  Abstract
  3. Goren T., FISCHER D. & Rubinstein M. (1986) Biochimica Et Biophysica Acta. 887, 1, p. 80-85  Abstract
  4. A NEUROTROPHIC FACTOR DERIVED FROM GOLDFISH BRAIN - CHARACTERIZATION AND PURIFICATION
    Mizrachi Y., Rubinstein M., KIMHI Y. & Schwartz M. (1986) Journal of Neurochemistry. 46, 6, p. 1675-1682  Abstract
  5. MORY Y., BENBARAK J., SEGEV D. et_al. (1986) Dna-A Journal Of Molecular & Cellular Biology. 5, 3, p. 181-193  Abstract
  6. THE INTERFERON-GAMMA RECEPTOR IN HUMAN-MONOCYTES IS DIFFERENT FROM THE ONE IN NONHEMATOPOIETIC CELLS
    ORCHANSKY P., Rubinstein M. & FISCHER D. (1986) Journal of Immunology. 136, 1, p. 169-173  Abstract
  7. Rubinstein M. & ORCHANSKY P. (1986) Crc Critical Reviews In Biochemistry. 21, 3, p. 249-275  Abstract

1985

  1. ROSENBERG H., MADAR Z., GERTLER A., Rubinstein M. & BINO T. (1985) Journal of Interferon Research. 5, 1, p. 121-127  Abstract

1984

  1. ORCHANSKY P., Novick D., FISCHER D. & Rubinstein M. (1984) Journal of Interferon Research. 4, 2, p. 275-282  Abstract
  2. CHERNAJOVSKY Y., MORY Y., CHEN L., MARKS Z., Novick D., Rubinstein M. & Revel M. (1984) Dna-A Journal Of Molecular & Cellular Biology. 3, 4, p. 297-308  Abstract
  3. FINEL M., Rubinstein M. & Pick U. (1984) FEBS Letters. 166, 1, p. 85-89  Abstract
  4. FRIEDLANDER J., FISCHER D. & Rubinstein M. (1984) Analytical Biochemistry. 137, 1, p. 115-119  Abstract

1983

  1. Goren T., Kapitkovsky A., Kimchi A. & Rubinstein M. (1983) Virology. 130, 2, p. 273-280  Abstract
  2. MONOCLONAL-ANTIBODIES TO HUMAN INTERFERON-GAMMA - PRODUCTION, AFFINITY PURIFICATION AND RADIOIMMUNOASSAY
    Novick D., Eshhar Z., FISCHER D., FRIEDLANDER J. & Rubinstein M. (1983) EMBO Journal. 2, 9, p. 1527-1530  Abstract
  3. Novick D., Eshhar Z., GIGI O., MARKS Z., Revel M. & Rubinstein M. (1983) Journal of General Virology. 64, APR, p. 905-910  Abstract

1982

  1. Fellous M., NIR U., Wallach D., MERLIN G., Rubinstein M. & Revel M. (1982) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 79, 10, p. 3082-3086  Abstract
  2. Rubinstein M. (1982) PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES. 299, 1094, p. 39-50  Abstract
  3. Rubinstein M. (1982) Biochimica Et Biophysica Acta. 695, 1, p. 5-16  Abstract
  4. ORCHANSKY P., Rubinstein M. & Sela I. (1982) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 79, 7, p. 2278-2280  Abstract
  5. MONOCLONAL-ANTIBODIES TO HUMAN ALPHA-INTERFERON AND THEIR USE FOR AFFINITY-CHROMATOGRAPHY
    Novick D., Eshhar Z. & Rubinstein M. (1982) Journal of Immunology. 129, 5, p. 2244-2247  Abstract

1976

  1. Rubinstein M., Shechter Y. & Patchornik A. (1976) Biochemical and Biophysical Research Communications. 70, 4, p. 1257-1263  Abstract

1975

  1. Shechter Y., Rubinstein M., BECKER R. & BOHAK Z. (1975) FEBS Journal. 58, 1, p. 123-131  Abstract
  2. USE OF A LIGHT-SENSITIVE PHOSPHATE PROTECTING GROUP FOR SOME MONONUCLEOTIDE SYNTHESES
    Rubinstein M., AMIT B. & Patchornik A. (1975) Tetrahedron Letters. 17, p. 1445-1448  Abstract
  3. Rubinstein M. & Patchornik A. (1975) Tetrahedron. 31, 17, p. 2107-2110  Abstract
  4. Rubinstein M. & Patchornik A. (1975) Tetrahedron. 31, 13-1, p. 1517-1519  Abstract